In mouse models of PD, sleep‐modulating treatments that enhanced slow waves exhibited a reduction in pathological alpha‐synuclein accumulation compared with the control groups, whereas non‐pharmacological sleep deprivation notably increased these pathological burdens.8 This evidence concerns the gene SNCA and Parkinson disease.